Table 2.

Point estimates of primary and secondary clinical outcomes

Variable	ATG group (95% CI)	PTCy group (95% CI)	P
GRFS
1 y, total	0.16 (0.08-0.31)	0.54 (0.44-0.66)	<.001
1 y, BM only	0.08 (0.01-0.54)	0.61 (0.48-0.78)
1 y, PB only	0.19 (0.09-0.38)	0.47 (0.34-0.66)
OS			<.001
1 y	0.45 (0.32-0.62)	0.75 (0.66-0.85)
2 y	0.29 (0.18-0.46)	0.66 (0.56-0.78)
Event-free survival			<.001
1 y	0.38 (0.26-0.55)	0.69 (0.59-0.80)
2 y	0.27 (0.17-0.44)	0.63 (0.53-0.75)
Relapse			.3
1 y	0.24 (0.13-0.38)	0.16 (0.09-0.25)
2 y	0.26 (0.15-0.4)	0.19 (0.11-0.29)
NRM			<.001
1 y	0.38 (0.23-0.52)	0.16 (0.09-0.25)
2 y	0.47 (0.31-0.60)	0.19 (0.11-0.28)
Acute GVHD (grades 3-4)
180 d, total	0.31 (0.18-0.45)	0.15 (0.08-0.23)	.03
180 d, BM only	0.25 (0.05-0.52)	0.10 (0.03-0.21)
180 d, PB only	0.33 (0.17-0.49)	0.20 (0.09-0.33)
Chronic GVHD
1 y, total	0.22 (0.11-0.35)	0.09 (0.04-0.17)	.03
1 y, BM only	0.08 (0.00-0.33)	0.10 (0.03-0.21)
1 y, PB only	0.26 (0.13-0.42)	0.08 (0.02-0.19)